These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17325965)

  • 21. Factor VIII inhibitors. Laboratory diagnosis of inhibitors.
    Sahud MA
    Semin Thromb Hemost; 2000; 26(2):195-203. PubMed ID: 10919413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinically significant inhibitors in hemophilia A patients from India tend to persist.
    Shetty S; Ghosh K; Pathare A; Mohanty D
    Acta Haematol; 2000; 103(3):175-6. PubMed ID: 10940659
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.
    Santagostino E; Gringeri A; Tagliavacca L; Mannucci PM
    Thromb Haemost; 1995 Aug; 74(2):619-21. PubMed ID: 8584995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of clot-based, chromogenic and fluorescence assays for measurement of factor VIII inhibitors in the US Hemophilia Inhibitor Research Study.
    Miller CH; Rice AS; Boylan B; Shapiro AD; Lentz SR; Wicklund BM; Kelly FM; Soucie JM;
    J Thromb Haemost; 2013 Jul; 11(7):1300-9. PubMed ID: 23601690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor VIII inhibitor developed in a 60-year-old patient with mild hemophilia A after surgery for colon cancer.
    Suzuki T; Arai M; Miyasaka S; Watanabe J; Sugimura D; Amano K; Yamagishi T; Kagawa K; Fukue H; Fukutake K
    Int J Hematol; 1995 Aug; 62(2):127-32. PubMed ID: 8590774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII.
    Sultan Y; White GC; Aronstam A; Bosser C; Brackmann HH; Brochier G; Gormsen J; Mariani G; Roberts HR; Scarabin Y
    Nouv Rev Fr Hematol (1978); 1986; 28(2):85-9. PubMed ID: 3090516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
    Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
    Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA antigens and factor VIII antibody in classic hemophilia. European study group of factor VIII antibody.
    Frommel D; Allain JP; Saint-Paul E; Bosser C; Noël B; Mannucci PM; Pannicucci F; Blombäck M; Prou-Wartelle O; Muller JY
    Thromb Haemost; 1981 Dec; 46(4):687-9. PubMed ID: 6800049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A.
    Sawecka J; Skulimowska J; Windyga J; Lopaciuk S; Kościelak J
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):352-6. PubMed ID: 16088320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitors of factor VIII in black patients with hemophilia.
    Viel KR; Ameri A; Abshire TC; Iyer RV; Watts RG; Lutcher C; Channell C; Cole SA; Fernstrom KM; Nakaya S; Kasper CK; Thompson AR; Almasy L; Howard TE
    N Engl J Med; 2009 Apr; 360(16):1618-27. PubMed ID: 19369668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product.
    Rangarajan S; Jiménez-Yuste V; Santagostino E
    Haemophilia; 2014 Nov; 20(6):e414-7. PubMed ID: 25333452
    [No Abstract]   [Full Text] [Related]  

  • 32. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance.
    Rothschild C; Laurian Y; Satre EP; Borel Derlon A; Chambost H; Moreau P; Goudemand J; Parquet A; Peynet J; Vicariot M; Beurrier P; Claeyssens S; Durin A; Faradji A; Fressinaud E; Gaillard S; Guérin V; Guérois C; Pernod G; Pouzol P; Schved JF; Gazengel C
    Thromb Haemost; 1998 Nov; 80(5):779-83. PubMed ID: 9843171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FVIII and FIX inhibitors in people living with hemophilia in Cameroon, Africa: a preliminary study.
    Balôgôg PN; Tagny CT; Ndoumba A; Mbanya D
    Int J Lab Hematol; 2014 Oct; 36(5):566-70. PubMed ID: 25356499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia.
    Wootla B; Mahendra A; Dimitrov JD; Friboulet A; Borel-Derlon A; Rao DN; Uda T; Borg JY; Bayry J; Kaveri SV; Lacroix-Desmazes S
    FEBS Lett; 2009 Aug; 583(15):2565-72. PubMed ID: 19595998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific and global coagulation tests in patients with mild haemophilia A with a double mutation (Glu113Asp, Arg593Cys).
    Trampuš Bakija A; Debeljak M; Preložnik Zupan I; Benedik Dolničar M; Kovač J; Jazbec J
    Blood Transfus; 2015 Oct; 13(4):622-30. PubMed ID: 26057490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nijmegen-Bethesda assay to measure factor VIII inhibitors.
    Duncan E; Collecutt M; Street A
    Methods Mol Biol; 2013; 992():321-33. PubMed ID: 23546724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of human factor VIII inhibitors in rats by immunization with human recombinant factor VIII: a small animal model for humans with high responder inhibitor phenotype.
    Jarvis MA; Levin LG; Harrison JA; DePianto DJ; Suzuki CM; Ziaja CL; Brown JE; Jolly KW; Reisner HM; Abildgaard CF; Powell JS
    Thromb Haemost; 1996 Feb; 75(2):318-25. PubMed ID: 8815584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.